Adenosine Exporter India, Manufacturer, Wholesaler & Distributor

Adenosine Injection: Rapid-Acting Antiarrhythmic for Supraventricular Tachycardia (SVT)

Adenosine Injection is a short-acting antiarrhythmic agent primarily used to restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (e.g., Wolff-Parkinson-White syndrome). It works by slowing conduction through the atrioventricular (AV) node, momentarily interrupting abnormal electrical circuits in the heart and allowing normal rhythm to resume.

• Adenosine binds to A1 receptors in the heart, reducing calcium influx and increasing potassium efflux, which results in transient AV nodal block

• Its ultra-short half-life (~10 seconds) allows precise control and rapid therapeutic action

• Additionally studied for its role in ocular blood flow regulation, with endogenous adenosine being linked to glaucoma pathophysiology

• Therapeutic Uses

  • Paroxysmal Supraventricular Tachycardia (PSVT)

  • Wolff-Parkinson-White Syndrome (as a diagnostic and therapeutic agent)

  • Pharmacologic stress testing (in myocardial perfusion imaging, off-label)

  • Investigational role in glaucoma therapy (via modulation of intraocular pressure)

  • Global Export Reach

    Key export destinations include: India, Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, Turkey